Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Electronic Arts is betting that in-game ads can out-earn CTV
To make in-game ads stick, EA has built its own stack rather than rent one. Now it wants to shape the standards before anyone else does.
Future of Marketing Briefing: Why Bose is building an entertainment company
Bose has a new entertainment division. Its CMO hasn’t used a creative agency in five years. The two things are related.
The rise of pharma ad tech
Insiders say it comes at the cost of legacy platforms such as DSPs and SSPs.